nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C9—Disulfiram—alcohol dependence	0.159	0.285	CbGbCtD
Bicalutamide—CYP2C19—Citalopram—alcohol dependence	0.136	0.245	CbGbCtD
Bicalutamide—CYP2D6—Citalopram—alcohol dependence	0.104	0.186	CbGbCtD
Bicalutamide—CYP3A4—Disulfiram—alcohol dependence	0.0925	0.166	CbGbCtD
Bicalutamide—CYP3A4—Citalopram—alcohol dependence	0.0659	0.118	CbGbCtD
Bicalutamide—AR—seminiferous tubule of testis—alcohol dependence	0.0142	0.278	CbGeAlD
Bicalutamide—AR—semen—alcohol dependence	0.00785	0.154	CbGeAlD
Bicalutamide—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00362	0.0406	CbGpPWpGaD
Bicalutamide—CYP2D6—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00355	0.0398	CbGpPWpGaD
Bicalutamide—CYP2D6—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00294	0.033	CbGpPWpGaD
Bicalutamide—CYP2D6—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.0025	0.028	CbGpPWpGaD
Bicalutamide—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00232	0.026	CbGpPWpGaD
Bicalutamide—CYP2D6—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00212	0.0238	CbGpPWpGaD
Bicalutamide—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00192	0.0215	CbGpPWpGaD
Bicalutamide—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00186	0.0209	CbGpPWpGaD
Bicalutamide—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00163	0.0183	CbGpPWpGaD
Bicalutamide—AR—forebrain—alcohol dependence	0.00157	0.0307	CbGeAlD
Bicalutamide—CYP2C19—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00154	0.0173	CbGpPWpGaD
Bicalutamide—AR—adrenal cortex—alcohol dependence	0.00145	0.0285	CbGeAlD
Bicalutamide—CYP2D6—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00142	0.0159	CbGpPWpGaD
Bicalutamide—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.0014	0.0157	CbGpPWpGaD
Bicalutamide—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00139	0.0156	CbGpPWpGaD
Bicalutamide—AR—cardiovascular system—alcohol dependence	0.00133	0.026	CbGeAlD
Bicalutamide—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00131	0.0147	CbGpPWpGaD
Bicalutamide—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00122	0.0137	CbGpPWpGaD
Bicalutamide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00122	0.0137	CbGpPWpGaD
Bicalutamide—AR—gonad—alcohol dependence	0.0012	0.0236	CbGeAlD
Bicalutamide—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00116	0.013	CbGpPWpGaD
Bicalutamide—AR—digestive system—alcohol dependence	0.0011	0.0216	CbGeAlD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00109	0.0122	CbGpPWpGaD
Bicalutamide—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00105	0.0118	CbGpPWpGaD
Bicalutamide—AR—blood—alcohol dependence	0.00105	0.0206	CbGeAlD
Bicalutamide—CYP2C19—digestive system—alcohol dependence	0.00102	0.02	CbGeAlD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000998	0.0112	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00099	0.0111	CbGpPWpGaD
Bicalutamide—CYP2C19—blood—alcohol dependence	0.000971	0.019	CbGeAlD
Bicalutamide—CYP2C19—Xenobiotics—CYP2E1—alcohol dependence	0.000954	0.0107	CbGpPWpGaD
Bicalutamide—CYP2C9—cardiovascular system—alcohol dependence	0.000952	0.0187	CbGeAlD
Bicalutamide—CYP2C19—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000918	0.0103	CbGpPWpGaD
Bicalutamide—AR—endocrine gland—alcohol dependence	0.000909	0.0178	CbGeAlD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000899	0.0101	CbGpPWpGaD
Bicalutamide—Pneumonia—Naltrexone—alcohol dependence	0.000884	0.00292	CcSEcCtD
Bicalutamide—CYP2D6—Xenobiotics—CYP2E1—alcohol dependence	0.000877	0.00984	CbGpPWpGaD
Bicalutamide—Depression—Naltrexone—alcohol dependence	0.000876	0.0029	CcSEcCtD
Bicalutamide—Epistaxis—Acamprosate—alcohol dependence	0.000876	0.0029	CcSEcCtD
Bicalutamide—CYP2D6—brainstem—alcohol dependence	0.000875	0.0172	CbGeAlD
Bicalutamide—Hypertonia—Citalopram—alcohol dependence	0.000873	0.00288	CcSEcCtD
Bicalutamide—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.00087	0.00976	CbGpPWpGaD
Bicalutamide—Abnormal vision—Citalopram—alcohol dependence	0.000868	0.00287	CcSEcCtD
Bicalutamide—AR—testis—alcohol dependence	0.000867	0.017	CbGeAlD
Bicalutamide—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000866	0.00286	CcSEcCtD
Bicalutamide—Sepsis—Citalopram—alcohol dependence	0.000864	0.00285	CcSEcCtD
Bicalutamide—Asthenia—Disulfiram—alcohol dependence	0.000863	0.00285	CcSEcCtD
Bicalutamide—Myocardial infarction—Naltrexone—alcohol dependence	0.000861	0.00285	CcSEcCtD
Bicalutamide—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000858	0.00962	CbGpPWpGaD
Bicalutamide—Conjunctivitis—Naltrexone—alcohol dependence	0.000854	0.00282	CcSEcCtD
Bicalutamide—Urinary tract infection—Naltrexone—alcohol dependence	0.000854	0.00282	CcSEcCtD
Bicalutamide—AR—nervous system—alcohol dependence	0.000851	0.0167	CbGeAlD
Bicalutamide—CYP2D6—forebrain—alcohol dependence	0.000845	0.0166	CbGeAlD
Bicalutamide—CYP2D6—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000844	0.00947	CbGpPWpGaD
Bicalutamide—CYP2C19—endocrine gland—alcohol dependence	0.000842	0.0165	CbGeAlD
Bicalutamide—Haemoglobin—Acamprosate—alcohol dependence	0.000838	0.00277	CcSEcCtD
Bicalutamide—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000837	0.00939	CbGpPWpGaD
Bicalutamide—Rhinitis—Acamprosate—alcohol dependence	0.000836	0.00276	CcSEcCtD
Bicalutamide—Haemorrhage—Acamprosate—alcohol dependence	0.000834	0.00276	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000831	0.00275	CcSEcCtD
Bicalutamide—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.000831	0.00275	CcSEcCtD
Bicalutamide—Diabetes mellitus—Citalopram—alcohol dependence	0.000831	0.00275	CcSEcCtD
Bicalutamide—Epistaxis—Naltrexone—alcohol dependence	0.000829	0.00274	CcSEcCtD
Bicalutamide—Pharyngitis—Acamprosate—alcohol dependence	0.000828	0.00274	CcSEcCtD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000827	0.00928	CbGpPWpGaD
Bicalutamide—Sinusitis—Naltrexone—alcohol dependence	0.000825	0.00272	CcSEcCtD
Bicalutamide—Oedema peripheral—Acamprosate—alcohol dependence	0.000821	0.00271	CcSEcCtD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00082	0.0092	CbGpPWpGaD
Bicalutamide—AR—liver—alcohol dependence	0.000819	0.0161	CbGeAlD
Bicalutamide—AR—central nervous system—alcohol dependence	0.000819	0.0161	CbGeAlD
Bicalutamide—Hepatic failure—Citalopram—alcohol dependence	0.000804	0.00266	CcSEcCtD
Bicalutamide—Visual impairment—Acamprosate—alcohol dependence	0.000804	0.00266	CcSEcCtD
Bicalutamide—Dizziness—Disulfiram—alcohol dependence	0.000795	0.00263	CcSEcCtD
Bicalutamide—CYP2C9—digestive system—alcohol dependence	0.00079	0.0155	CbGeAlD
Bicalutamide—Pharyngitis—Naltrexone—alcohol dependence	0.000783	0.00259	CcSEcCtD
Bicalutamide—Libido decreased—Citalopram—alcohol dependence	0.000779	0.00258	CcSEcCtD
Bicalutamide—Hot flush—Citalopram—alcohol dependence	0.000772	0.00255	CcSEcCtD
Bicalutamide—Menopausal symptoms—Citalopram—alcohol dependence	0.000766	0.00253	CcSEcCtD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000765	0.00858	CbGpPWpGaD
Bicalutamide—Atrial fibrillation—Citalopram—alcohol dependence	0.000763	0.00252	CcSEcCtD
Bicalutamide—CYP2C19—liver—alcohol dependence	0.000759	0.0149	CbGeAlD
Bicalutamide—Rash—Disulfiram—alcohol dependence	0.000758	0.00251	CcSEcCtD
Bicalutamide—Headache—Disulfiram—alcohol dependence	0.000753	0.00249	CcSEcCtD
Bicalutamide—Immune system disorder—Acamprosate—alcohol dependence	0.000753	0.00249	CcSEcCtD
Bicalutamide—CYP2C9—blood—alcohol dependence	0.000753	0.0148	CbGeAlD
Bicalutamide—Chills—Acamprosate—alcohol dependence	0.000748	0.00247	CcSEcCtD
Bicalutamide—Arthritis—Citalopram—alcohol dependence	0.000743	0.00246	CcSEcCtD
Bicalutamide—Hypoglycaemia—Citalopram—alcohol dependence	0.00074	0.00245	CcSEcCtD
Bicalutamide—Cardiac failure—Citalopram—alcohol dependence	0.00074	0.00245	CcSEcCtD
Bicalutamide—Cerebrovascular accident—Citalopram—alcohol dependence	0.000737	0.00244	CcSEcCtD
Bicalutamide—Alopecia—Acamprosate—alcohol dependence	0.000737	0.00244	CcSEcCtD
Bicalutamide—Cardiac disorder—Naltrexone—alcohol dependence	0.000732	0.00242	CcSEcCtD
Bicalutamide—Mental disorder—Acamprosate—alcohol dependence	0.000731	0.00241	CcSEcCtD
Bicalutamide—Malnutrition—Acamprosate—alcohol dependence	0.000726	0.0024	CcSEcCtD
Bicalutamide—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000717	0.00237	CcSEcCtD
Bicalutamide—Angiopathy—Naltrexone—alcohol dependence	0.000716	0.00237	CcSEcCtD
Bicalutamide—Flatulence—Acamprosate—alcohol dependence	0.000715	0.00236	CcSEcCtD
Bicalutamide—Immune system disorder—Naltrexone—alcohol dependence	0.000713	0.00236	CcSEcCtD
Bicalutamide—Tension—Acamprosate—alcohol dependence	0.000712	0.00235	CcSEcCtD
Bicalutamide—Mediastinal disorder—Naltrexone—alcohol dependence	0.000711	0.00235	CcSEcCtD
Bicalutamide—Chills—Naltrexone—alcohol dependence	0.000708	0.00234	CcSEcCtD
Bicalutamide—Nervousness—Acamprosate—alcohol dependence	0.000705	0.00233	CcSEcCtD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000703	0.00789	CbGpPWpGaD
Bicalutamide—Back pain—Acamprosate—alcohol dependence	0.000702	0.00232	CcSEcCtD
Bicalutamide—Muscle spasms—Acamprosate—alcohol dependence	0.000698	0.00231	CcSEcCtD
Bicalutamide—Face oedema—Citalopram—alcohol dependence	0.000698	0.00231	CcSEcCtD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000697	0.00782	CbGpPWpGaD
Bicalutamide—Alopecia—Naltrexone—alcohol dependence	0.000697	0.0023	CcSEcCtD
Bicalutamide—Mental disorder—Naltrexone—alcohol dependence	0.000691	0.00228	CcSEcCtD
Bicalutamide—Urinary retention—Citalopram—alcohol dependence	0.000687	0.00227	CcSEcCtD
Bicalutamide—Cardiac arrest—Citalopram—alcohol dependence	0.000687	0.00227	CcSEcCtD
Bicalutamide—Malnutrition—Naltrexone—alcohol dependence	0.000687	0.00227	CcSEcCtD
Bicalutamide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000686	0.00769	CbGpPWpGaD
Bicalutamide—Flatulence—Naltrexone—alcohol dependence	0.000677	0.00224	CcSEcCtD
Bicalutamide—Tension—Naltrexone—alcohol dependence	0.000674	0.00223	CcSEcCtD
Bicalutamide—Dehydration—Citalopram—alcohol dependence	0.000672	0.00222	CcSEcCtD
Bicalutamide—Anaemia—Acamprosate—alcohol dependence	0.000671	0.00222	CcSEcCtD
Bicalutamide—Liver function test abnormal—Citalopram—alcohol dependence	0.000667	0.0022	CcSEcCtD
Bicalutamide—Nervousness—Naltrexone—alcohol dependence	0.000667	0.0022	CcSEcCtD
Bicalutamide—Back pain—Naltrexone—alcohol dependence	0.000664	0.0022	CcSEcCtD
Bicalutamide—Angioedema—Acamprosate—alcohol dependence	0.000663	0.00219	CcSEcCtD
Bicalutamide—Dry skin—Citalopram—alcohol dependence	0.000662	0.00219	CcSEcCtD
Bicalutamide—Muscle spasms—Naltrexone—alcohol dependence	0.00066	0.00218	CcSEcCtD
Bicalutamide—Breast disorder—Citalopram—alcohol dependence	0.000653	0.00216	CcSEcCtD
Bicalutamide—CYP2C9—endocrine gland—alcohol dependence	0.000653	0.0128	CbGeAlD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000653	0.00732	CbGpPWpGaD
Bicalutamide—Syncope—Acamprosate—alcohol dependence	0.000651	0.00215	CcSEcCtD
Bicalutamide—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000651	0.00215	CcSEcCtD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00065	0.0073	CbGpPWpGaD
Bicalutamide—AR—brain—alcohol dependence	0.00065	0.0128	CbGeAlD
Bicalutamide—Gastritis—Citalopram—alcohol dependence	0.000639	0.00211	CcSEcCtD
Bicalutamide—Loss of consciousness—Acamprosate—alcohol dependence	0.000638	0.00211	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000637	0.00211	CcSEcCtD
Bicalutamide—Muscular weakness—Citalopram—alcohol dependence	0.000637	0.00211	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000637	0.00715	CbGpPWpGaD
Bicalutamide—Cough—Acamprosate—alcohol dependence	0.000633	0.00209	CcSEcCtD
Bicalutamide—Angioedema—Naltrexone—alcohol dependence	0.000628	0.00207	CcSEcCtD
Bicalutamide—Hypertension—Acamprosate—alcohol dependence	0.000627	0.00207	CcSEcCtD
Bicalutamide—Dysphagia—Citalopram—alcohol dependence	0.000625	0.00206	CcSEcCtD
Bicalutamide—Asthma—Citalopram—alcohol dependence	0.000625	0.00206	CcSEcCtD
Bicalutamide—Influenza—Citalopram—alcohol dependence	0.000625	0.00206	CcSEcCtD
Bicalutamide—Eosinophilia—Citalopram—alcohol dependence	0.000618	0.00204	CcSEcCtD
Bicalutamide—Chest pain—Acamprosate—alcohol dependence	0.000618	0.00204	CcSEcCtD
Bicalutamide—Myalgia—Acamprosate—alcohol dependence	0.000618	0.00204	CcSEcCtD
Bicalutamide—Syncope—Naltrexone—alcohol dependence	0.000616	0.00204	CcSEcCtD
Bicalutamide—Anxiety—Acamprosate—alcohol dependence	0.000616	0.00204	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000614	0.00203	CcSEcCtD
Bicalutamide—Angina pectoris—Citalopram—alcohol dependence	0.000608	0.00201	CcSEcCtD
Bicalutamide—Dry mouth—Acamprosate—alcohol dependence	0.000604	0.002	CcSEcCtD
Bicalutamide—Loss of consciousness—Naltrexone—alcohol dependence	0.000604	0.00199	CcSEcCtD
Bicalutamide—CYP3A4—digestive system—alcohol dependence	0.000602	0.0118	CbGeAlD
Bicalutamide—Bronchitis—Citalopram—alcohol dependence	0.000601	0.00198	CcSEcCtD
Bicalutamide—Cough—Naltrexone—alcohol dependence	0.000599	0.00198	CcSEcCtD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000598	0.00671	CbGpPWpGaD
Bicalutamide—Confusional state—Acamprosate—alcohol dependence	0.000597	0.00197	CcSEcCtD
Bicalutamide—Hypertension—Naltrexone—alcohol dependence	0.000593	0.00196	CcSEcCtD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000593	0.00665	CbGpPWpGaD
Bicalutamide—CYP2D6—digestive system—alcohol dependence	0.000593	0.0116	CbGeAlD
Bicalutamide—CYP2C9—liver—alcohol dependence	0.000589	0.0115	CbGeAlD
Bicalutamide—Infection—Acamprosate—alcohol dependence	0.000589	0.00195	CcSEcCtD
Bicalutamide—Chest pain—Naltrexone—alcohol dependence	0.000585	0.00193	CcSEcCtD
Bicalutamide—Myalgia—Naltrexone—alcohol dependence	0.000585	0.00193	CcSEcCtD
Bicalutamide—Dysuria—Citalopram—alcohol dependence	0.000584	0.00193	CcSEcCtD
Bicalutamide—CYP2C19—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000583	0.00654	CbGpPWpGaD
Bicalutamide—Shock—Acamprosate—alcohol dependence	0.000583	0.00193	CcSEcCtD
Bicalutamide—Anxiety—Naltrexone—alcohol dependence	0.000583	0.00193	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000581	0.00192	CcSEcCtD
Bicalutamide—Thrombocytopenia—Acamprosate—alcohol dependence	0.00058	0.00192	CcSEcCtD
Bicalutamide—Pollakiuria—Citalopram—alcohol dependence	0.000577	0.00191	CcSEcCtD
Bicalutamide—CYP2C19—Biological oxidations—ADH6—alcohol dependence	0.000577	0.00647	CbGpPWpGaD
Bicalutamide—Skin disorder—Acamprosate—alcohol dependence	0.000575	0.0019	CcSEcCtD
Bicalutamide—Erectile dysfunction—Citalopram—alcohol dependence	0.000575	0.0019	CcSEcCtD
Bicalutamide—CYP3A4—blood—alcohol dependence	0.000574	0.0113	CbGeAlD
Bicalutamide—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000574	0.00644	CbGpPWpGaD
Bicalutamide—Hyperhidrosis—Acamprosate—alcohol dependence	0.000573	0.00189	CcSEcCtD
Bicalutamide—Dry mouth—Naltrexone—alcohol dependence	0.000572	0.00189	CcSEcCtD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00057	0.0064	CbGpPWpGaD
Bicalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000569	0.00638	CbGpPWpGaD
Bicalutamide—Weight increased—Citalopram—alcohol dependence	0.000568	0.00188	CcSEcCtD
Bicalutamide—Confusional state—Naltrexone—alcohol dependence	0.000565	0.00187	CcSEcCtD
Bicalutamide—Weight decreased—Citalopram—alcohol dependence	0.000565	0.00187	CcSEcCtD
Bicalutamide—CYP2D6—blood—alcohol dependence	0.000565	0.0111	CbGeAlD
Bicalutamide—Anorexia—Acamprosate—alcohol dependence	0.000565	0.00187	CcSEcCtD
Bicalutamide—Hyperglycaemia—Citalopram—alcohol dependence	0.000563	0.00186	CcSEcCtD
Bicalutamide—Oedema—Naltrexone—alcohol dependence	0.000561	0.00185	CcSEcCtD
Bicalutamide—Pneumonia—Citalopram—alcohol dependence	0.00056	0.00185	CcSEcCtD
Bicalutamide—Infection—Naltrexone—alcohol dependence	0.000557	0.00184	CcSEcCtD
Bicalutamide—Depression—Citalopram—alcohol dependence	0.000555	0.00184	CcSEcCtD
Bicalutamide—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000552	0.00619	CbGpPWpGaD
Bicalutamide—Shock—Naltrexone—alcohol dependence	0.000551	0.00182	CcSEcCtD
Bicalutamide—Nervous system disorder—Naltrexone—alcohol dependence	0.00055	0.00182	CcSEcCtD
Bicalutamide—Acute coronary syndrome—Citalopram—alcohol dependence	0.000549	0.00181	CcSEcCtD
Bicalutamide—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000549	0.00616	CbGpPWpGaD
Bicalutamide—Myocardial infarction—Citalopram—alcohol dependence	0.000546	0.0018	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Citalopram—alcohol dependence	0.000546	0.0018	CcSEcCtD
Bicalutamide—Skin disorder—Naltrexone—alcohol dependence	0.000544	0.0018	CcSEcCtD
Bicalutamide—Jaundice—Citalopram—alcohol dependence	0.000543	0.00179	CcSEcCtD
Bicalutamide—Hyperhidrosis—Naltrexone—alcohol dependence	0.000542	0.00179	CcSEcCtD
Bicalutamide—Urinary tract infection—Citalopram—alcohol dependence	0.000541	0.00179	CcSEcCtD
Bicalutamide—Conjunctivitis—Citalopram—alcohol dependence	0.000541	0.00179	CcSEcCtD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000541	0.00607	CbGpPWpGaD
Bicalutamide—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00054	0.00178	CcSEcCtD
Bicalutamide—CYP2D6—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000536	0.00602	CbGpPWpGaD
Bicalutamide—Insomnia—Acamprosate—alcohol dependence	0.000536	0.00177	CcSEcCtD
Bicalutamide—Anorexia—Naltrexone—alcohol dependence	0.000534	0.00177	CcSEcCtD
Bicalutamide—Sweating—Citalopram—alcohol dependence	0.000534	0.00176	CcSEcCtD
Bicalutamide—Paraesthesia—Acamprosate—alcohol dependence	0.000532	0.00176	CcSEcCtD
Bicalutamide—Haematuria—Citalopram—alcohol dependence	0.000531	0.00175	CcSEcCtD
Bicalutamide—CYP2D6—Biological oxidations—ADH6—alcohol dependence	0.00053	0.00595	CbGpPWpGaD
Bicalutamide—Dyspnoea—Acamprosate—alcohol dependence	0.000528	0.00175	CcSEcCtD
Bicalutamide—Somnolence—Acamprosate—alcohol dependence	0.000527	0.00174	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Citalopram—alcohol dependence	0.000527	0.00174	CcSEcCtD
Bicalutamide—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000526	0.0059	CbGpPWpGaD
Bicalutamide—Epistaxis—Citalopram—alcohol dependence	0.000525	0.00174	CcSEcCtD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000524	0.00588	CbGpPWpGaD
Bicalutamide—Sinusitis—Citalopram—alcohol dependence	0.000522	0.00173	CcSEcCtD
Bicalutamide—Dyspepsia—Acamprosate—alcohol dependence	0.000521	0.00172	CcSEcCtD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00052	0.00583	CbGpPWpGaD
Bicalutamide—Decreased appetite—Acamprosate—alcohol dependence	0.000515	0.0017	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000511	0.00169	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000511	0.00169	CcSEcCtD
Bicalutamide—Bradycardia—Citalopram—alcohol dependence	0.000509	0.00168	CcSEcCtD
Bicalutamide—Insomnia—Naltrexone—alcohol dependence	0.000507	0.00168	CcSEcCtD
Bicalutamide—Constipation—Acamprosate—alcohol dependence	0.000507	0.00167	CcSEcCtD
Bicalutamide—Pain—Acamprosate—alcohol dependence	0.000507	0.00167	CcSEcCtD
Bicalutamide—Paraesthesia—Naltrexone—alcohol dependence	0.000503	0.00166	CcSEcCtD
Bicalutamide—Haemoglobin—Citalopram—alcohol dependence	0.000502	0.00166	CcSEcCtD
Bicalutamide—Rhinitis—Citalopram—alcohol dependence	0.000501	0.00166	CcSEcCtD
Bicalutamide—Haemorrhage—Citalopram—alcohol dependence	0.0005	0.00165	CcSEcCtD
Bicalutamide—Dyspnoea—Naltrexone—alcohol dependence	0.0005	0.00165	CcSEcCtD
Bicalutamide—Somnolence—Naltrexone—alcohol dependence	0.000498	0.00165	CcSEcCtD
Bicalutamide—CYP3A4—endocrine gland—alcohol dependence	0.000498	0.00976	CbGeAlD
Bicalutamide—Pharyngitis—Citalopram—alcohol dependence	0.000496	0.00164	CcSEcCtD
Bicalutamide—Urinary tract disorder—Citalopram—alcohol dependence	0.000494	0.00163	CcSEcCtD
Bicalutamide—Oedema peripheral—Citalopram—alcohol dependence	0.000492	0.00163	CcSEcCtD
Bicalutamide—Urethral disorder—Citalopram—alcohol dependence	0.00049	0.00162	CcSEcCtD
Bicalutamide—CYP2D6—endocrine gland—alcohol dependence	0.00049	0.00961	CbGeAlD
Bicalutamide—Feeling abnormal—Acamprosate—alcohol dependence	0.000488	0.00161	CcSEcCtD
Bicalutamide—Decreased appetite—Naltrexone—alcohol dependence	0.000487	0.00161	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000484	0.0016	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000484	0.0016	CcSEcCtD
Bicalutamide—Fatigue—Naltrexone—alcohol dependence	0.000483	0.0016	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000483	0.00542	CbGpPWpGaD
Bicalutamide—Visual impairment—Citalopram—alcohol dependence	0.000482	0.00159	CcSEcCtD
Bicalutamide—Constipation—Naltrexone—alcohol dependence	0.000479	0.00158	CcSEcCtD
Bicalutamide—Pain—Naltrexone—alcohol dependence	0.000479	0.00158	CcSEcCtD
Bicalutamide—CYP2C19—Biological oxidations—ADH1A—alcohol dependence	0.000478	0.00536	CbGpPWpGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000472	0.0053	CbGpPWpGaD
Bicalutamide—Urticaria—Acamprosate—alcohol dependence	0.000471	0.00156	CcSEcCtD
Bicalutamide—Body temperature increased—Acamprosate—alcohol dependence	0.000468	0.00155	CcSEcCtD
Bicalutamide—Abdominal pain—Acamprosate—alcohol dependence	0.000468	0.00155	CcSEcCtD
Bicalutamide—CYP2D6—testis—alcohol dependence	0.000467	0.00916	CbGeAlD
Bicalutamide—CYP3A4—nervous system—alcohol dependence	0.000466	0.00914	CbGeAlD
Bicalutamide—Cardiac disorder—Citalopram—alcohol dependence	0.000464	0.00153	CcSEcCtD
Bicalutamide—Feeling abnormal—Naltrexone—alcohol dependence	0.000462	0.00153	CcSEcCtD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00046	0.00516	CbGpPWpGaD
Bicalutamide—CYP2D6—nervous system—alcohol dependence	0.000459	0.00899	CbGeAlD
Bicalutamide—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000458	0.00151	CcSEcCtD
Bicalutamide—Angiopathy—Citalopram—alcohol dependence	0.000454	0.0015	CcSEcCtD
Bicalutamide—Immune system disorder—Citalopram—alcohol dependence	0.000452	0.00149	CcSEcCtD
Bicalutamide—Mediastinal disorder—Citalopram—alcohol dependence	0.000451	0.00149	CcSEcCtD
Bicalutamide—CYP3A4—liver—alcohol dependence	0.000449	0.0088	CbGeAlD
Bicalutamide—CYP3A4—central nervous system—alcohol dependence	0.000449	0.0088	CbGeAlD
Bicalutamide—Chills—Citalopram—alcohol dependence	0.000449	0.00148	CcSEcCtD
Bicalutamide—Arrhythmia—Citalopram—alcohol dependence	0.000447	0.00148	CcSEcCtD
Bicalutamide—Urticaria—Naltrexone—alcohol dependence	0.000445	0.00147	CcSEcCtD
Bicalutamide—Abdominal pain—Naltrexone—alcohol dependence	0.000443	0.00146	CcSEcCtD
Bicalutamide—Body temperature increased—Naltrexone—alcohol dependence	0.000443	0.00146	CcSEcCtD
Bicalutamide—Alopecia—Citalopram—alcohol dependence	0.000442	0.00146	CcSEcCtD
Bicalutamide—CYP2D6—liver—alcohol dependence	0.000442	0.00866	CbGeAlD
Bicalutamide—CYP2D6—central nervous system—alcohol dependence	0.000441	0.00866	CbGeAlD
Bicalutamide—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.000439	0.00493	CbGpPWpGaD
Bicalutamide—Mental disorder—Citalopram—alcohol dependence	0.000438	0.00145	CcSEcCtD
Bicalutamide—Hypersensitivity—Acamprosate—alcohol dependence	0.000436	0.00144	CcSEcCtD
Bicalutamide—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000436	0.00489	CbGpPWpGaD
Bicalutamide—Malnutrition—Citalopram—alcohol dependence	0.000435	0.00144	CcSEcCtD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000435	0.00488	CbGpPWpGaD
Bicalutamide—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000433	0.00486	CbGpPWpGaD
Bicalutamide—AR—FOXA1 transcription factor network—EP300—alcohol dependence	0.000432	0.00485	CbGpPWpGaD
Bicalutamide—CYP2D6—cerebellum—alcohol dependence	0.000431	0.00846	CbGeAlD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000431	0.00483	CbGpPWpGaD
Bicalutamide—Flatulence—Citalopram—alcohol dependence	0.000429	0.00142	CcSEcCtD
Bicalutamide—Tension—Citalopram—alcohol dependence	0.000427	0.00141	CcSEcCtD
Bicalutamide—Asthenia—Acamprosate—alcohol dependence	0.000425	0.0014	CcSEcCtD
Bicalutamide—Nervousness—Citalopram—alcohol dependence	0.000423	0.0014	CcSEcCtD
Bicalutamide—Back pain—Citalopram—alcohol dependence	0.000421	0.00139	CcSEcCtD
Bicalutamide—CYP2C19—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000421	0.00472	CbGpPWpGaD
Bicalutamide—Pruritus—Acamprosate—alcohol dependence	0.000419	0.00139	CcSEcCtD
Bicalutamide—Muscle spasms—Citalopram—alcohol dependence	0.000418	0.00138	CcSEcCtD
Bicalutamide—Hypersensitivity—Naltrexone—alcohol dependence	0.000413	0.00136	CcSEcCtD
Bicalutamide—AR—Notch-mediated HES/HEY network—EP300—alcohol dependence	0.00041	0.0046	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—ADH4—alcohol dependence	0.000406	0.00456	CbGpPWpGaD
Bicalutamide—Diarrhoea—Acamprosate—alcohol dependence	0.000405	0.00134	CcSEcCtD
Bicalutamide—Anaemia—Citalopram—alcohol dependence	0.000402	0.00133	CcSEcCtD
Bicalutamide—Asthenia—Naltrexone—alcohol dependence	0.000402	0.00133	CcSEcCtD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000402	0.00451	CbGpPWpGaD
Bicalutamide—Angioedema—Citalopram—alcohol dependence	0.000398	0.00131	CcSEcCtD
Bicalutamide—Pruritus—Naltrexone—alcohol dependence	0.000397	0.00131	CcSEcCtD
Bicalutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000396	0.00444	CbGpPWpGaD
Bicalutamide—Dizziness—Acamprosate—alcohol dependence	0.000392	0.00129	CcSEcCtD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000391	0.00439	CbGpPWpGaD
Bicalutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000391	0.00439	CbGpPWpGaD
Bicalutamide—Syncope—Citalopram—alcohol dependence	0.00039	0.00129	CcSEcCtD
Bicalutamide—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000384	0.00431	CbGpPWpGaD
Bicalutamide—Diarrhoea—Naltrexone—alcohol dependence	0.000384	0.00127	CcSEcCtD
Bicalutamide—Loss of consciousness—Citalopram—alcohol dependence	0.000382	0.00126	CcSEcCtD
Bicalutamide—Cough—Citalopram—alcohol dependence	0.00038	0.00125	CcSEcCtD
Bicalutamide—Vomiting—Acamprosate—alcohol dependence	0.000377	0.00124	CcSEcCtD
Bicalutamide—Hypertension—Citalopram—alcohol dependence	0.000376	0.00124	CcSEcCtD
Bicalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000375	0.00421	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.000374	0.00419	CbGpPWpGaD
Bicalutamide—Rash—Acamprosate—alcohol dependence	0.000374	0.00123	CcSEcCtD
Bicalutamide—Dermatitis—Acamprosate—alcohol dependence	0.000373	0.00123	CcSEcCtD
Bicalutamide—AR—Regulation of Androgen receptor activity—EP300—alcohol dependence	0.000372	0.00418	CbGpPWpGaD
Bicalutamide—Headache—Acamprosate—alcohol dependence	0.000371	0.00123	CcSEcCtD
Bicalutamide—Dizziness—Naltrexone—alcohol dependence	0.000371	0.00122	CcSEcCtD
Bicalutamide—Chest pain—Citalopram—alcohol dependence	0.00037	0.00122	CcSEcCtD
Bicalutamide—Myalgia—Citalopram—alcohol dependence	0.00037	0.00122	CcSEcCtD
Bicalutamide—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.00037	0.00416	CbGpPWpGaD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000369	0.00415	CbGpPWpGaD
Bicalutamide—Anxiety—Citalopram—alcohol dependence	0.000369	0.00122	CcSEcCtD
Bicalutamide—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000369	0.00414	CbGpPWpGaD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000368	0.00122	CcSEcCtD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000366	0.00411	CbGpPWpGaD
Bicalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000364	0.00409	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000363	0.00408	CbGpPWpGaD
Bicalutamide—Dry mouth—Citalopram—alcohol dependence	0.000362	0.0012	CcSEcCtD
Bicalutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000361	0.00405	CbGpPWpGaD
Bicalutamide—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00036	0.00403	CbGpPWpGaD
Bicalutamide—Confusional state—Citalopram—alcohol dependence	0.000358	0.00118	CcSEcCtD
Bicalutamide—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000356	0.004	CbGpPWpGaD
Bicalutamide—Vomiting—Naltrexone—alcohol dependence	0.000356	0.00118	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000356	0.00399	CbGpPWpGaD
Bicalutamide—Oedema—Citalopram—alcohol dependence	0.000355	0.00117	CcSEcCtD
Bicalutamide—Rash—Naltrexone—alcohol dependence	0.000353	0.00117	CcSEcCtD
Bicalutamide—Dermatitis—Naltrexone—alcohol dependence	0.000353	0.00117	CcSEcCtD
Bicalutamide—Infection—Citalopram—alcohol dependence	0.000353	0.00117	CcSEcCtD
Bicalutamide—Nausea—Acamprosate—alcohol dependence	0.000352	0.00116	CcSEcCtD
Bicalutamide—Headache—Naltrexone—alcohol dependence	0.000351	0.00116	CcSEcCtD
Bicalutamide—CYP2D6—brain—alcohol dependence	0.00035	0.00687	CbGeAlD
Bicalutamide—Shock—Citalopram—alcohol dependence	0.000349	0.00115	CcSEcCtD
Bicalutamide—Nervous system disorder—Citalopram—alcohol dependence	0.000348	0.00115	CcSEcCtD
Bicalutamide—Thrombocytopenia—Citalopram—alcohol dependence	0.000348	0.00115	CcSEcCtD
Bicalutamide—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000347	0.00389	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—ADH7—alcohol dependence	0.000345	0.00388	CbGpPWpGaD
Bicalutamide—Skin disorder—Citalopram—alcohol dependence	0.000345	0.00114	CcSEcCtD
Bicalutamide—Hyperhidrosis—Citalopram—alcohol dependence	0.000343	0.00113	CcSEcCtD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000343	0.00385	CbGpPWpGaD
Bicalutamide—Anorexia—Citalopram—alcohol dependence	0.000339	0.00112	CcSEcCtD
Bicalutamide—Nausea—Naltrexone—alcohol dependence	0.000333	0.0011	CcSEcCtD
Bicalutamide—CYP2C19—Biological oxidations—GGT2—alcohol dependence	0.000331	0.00372	CbGpPWpGaD
Bicalutamide—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000324	0.00107	CcSEcCtD
Bicalutamide—Insomnia—Citalopram—alcohol dependence	0.000321	0.00106	CcSEcCtD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000321	0.0036	CbGpPWpGaD
Bicalutamide—Paraesthesia—Citalopram—alcohol dependence	0.000319	0.00105	CcSEcCtD
Bicalutamide—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.000318	0.00356	CbGpPWpGaD
Bicalutamide—Dyspnoea—Citalopram—alcohol dependence	0.000317	0.00105	CcSEcCtD
Bicalutamide—Somnolence—Citalopram—alcohol dependence	0.000316	0.00104	CcSEcCtD
Bicalutamide—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000315	0.00353	CbGpPWpGaD
Bicalutamide—Dyspepsia—Citalopram—alcohol dependence	0.000313	0.00103	CcSEcCtD
Bicalutamide—Decreased appetite—Citalopram—alcohol dependence	0.000309	0.00102	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000307	0.00101	CcSEcCtD
Bicalutamide—Fatigue—Citalopram—alcohol dependence	0.000306	0.00101	CcSEcCtD
Bicalutamide—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000305	0.00342	CbGpPWpGaD
Bicalutamide—Pain—Citalopram—alcohol dependence	0.000304	0.001	CcSEcCtD
Bicalutamide—Constipation—Citalopram—alcohol dependence	0.000304	0.001	CcSEcCtD
Bicalutamide—CYP2C19—Biological oxidations—ADH1B—alcohol dependence	0.000303	0.0034	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000302	0.00339	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000296	0.00332	CbGpPWpGaD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000295	0.00331	CbGpPWpGaD
Bicalutamide—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000295	0.00331	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000293	0.00329	CbGpPWpGaD
Bicalutamide—Feeling abnormal—Citalopram—alcohol dependence	0.000293	0.000967	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Citalopram—alcohol dependence	0.00029	0.00096	CcSEcCtD
Bicalutamide—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000287	0.00322	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000284	0.00319	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—CCAR1—alcohol dependence	0.000282	0.00317	CbGpPWpGaD
Bicalutamide—Urticaria—Citalopram—alcohol dependence	0.000282	0.000932	CcSEcCtD
Bicalutamide—Abdominal pain—Citalopram—alcohol dependence	0.000281	0.000928	CcSEcCtD
Bicalutamide—Body temperature increased—Citalopram—alcohol dependence	0.000281	0.000928	CcSEcCtD
Bicalutamide—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000279	0.00313	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000276	0.0031	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—alcohol dependence	0.000268	0.003	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—EP300—alcohol dependence	0.000265	0.00297	CbGpPWpGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000264	0.00296	CbGpPWpGaD
Bicalutamide—Hypersensitivity—Citalopram—alcohol dependence	0.000262	0.000865	CcSEcCtD
Bicalutamide—Asthenia—Citalopram—alcohol dependence	0.000255	0.000842	CcSEcCtD
Bicalutamide—Pruritus—Citalopram—alcohol dependence	0.000251	0.00083	CcSEcCtD
Bicalutamide—CYP2C19—Biological oxidations—MAOB—alcohol dependence	0.000251	0.00282	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—EP300—alcohol dependence	0.000246	0.00276	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000244	0.00274	CbGpPWpGaD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000243	0.00273	CbGpPWpGaD
Bicalutamide—Diarrhoea—Citalopram—alcohol dependence	0.000243	0.000803	CcSEcCtD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000242	0.00271	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000241	0.0027	CbGpPWpGaD
Bicalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000238	0.00267	CbGpPWpGaD
Bicalutamide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000235	0.00264	CbGpPWpGaD
Bicalutamide—Dizziness—Citalopram—alcohol dependence	0.000235	0.000776	CcSEcCtD
Bicalutamide—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.000231	0.00259	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000229	0.00257	CbGpPWpGaD
Bicalutamide—Vomiting—Citalopram—alcohol dependence	0.000226	0.000746	CcSEcCtD
Bicalutamide—Rash—Citalopram—alcohol dependence	0.000224	0.00074	CcSEcCtD
Bicalutamide—Dermatitis—Citalopram—alcohol dependence	0.000224	0.000739	CcSEcCtD
Bicalutamide—Headache—Citalopram—alcohol dependence	0.000222	0.000735	CcSEcCtD
Bicalutamide—CYP2C19—Biological oxidations—ALDH2—alcohol dependence	0.000213	0.00239	CbGpPWpGaD
Bicalutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000212	0.00238	CbGpPWpGaD
Bicalutamide—Nausea—Citalopram—alcohol dependence	0.000211	0.000697	CcSEcCtD
Bicalutamide—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000208	0.00233	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000199	0.00223	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.000196	0.0022	CbGpPWpGaD
Bicalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000195	0.00219	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000195	0.00218	CbGpPWpGaD
Bicalutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000193	0.00217	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000193	0.00217	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000182	0.00204	CbGpPWpGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000172	0.00193	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—CYP2E1—alcohol dependence	0.000171	0.00191	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000168	0.00189	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000161	0.00181	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000159	0.00178	CbGpPWpGaD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000158	0.00178	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000157	0.00176	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000157	0.00176	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000157	0.00176	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GGT1—alcohol dependence	0.000157	0.00176	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000156	0.00175	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000155	0.00174	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000153	0.00172	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000151	0.00169	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GGT1—alcohol dependence	0.000144	0.00162	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000143	0.0016	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—MAOA—alcohol dependence	0.00014	0.00157	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000133	0.0015	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—MAOA—alcohol dependence	0.000129	0.00145	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000128	0.00144	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000128	0.00144	CbGpPWpGaD
Bicalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000128	0.00143	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000103	0.00116	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000103	0.00115	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000101	0.00114	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADH6—alcohol dependence	9.86e-05	0.00111	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GGT1—alcohol dependence	9.42e-05	0.00106	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—POMC—alcohol dependence	9.14e-05	0.00103	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADH6—alcohol dependence	9.07e-05	0.00102	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADH6—alcohol dependence	8.99e-05	0.00101	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—MAOA—alcohol dependence	8.44e-05	0.000947	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—POMC—alcohol dependence	8.4e-05	0.000943	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—POMC—alcohol dependence	8.33e-05	0.000935	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADH1A—alcohol dependence	8.17e-05	0.000917	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADH1A—alcohol dependence	7.51e-05	0.000843	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADH1A—alcohol dependence	7.45e-05	0.000836	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADH4—alcohol dependence	6.95e-05	0.000779	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADH4—alcohol dependence	6.39e-05	0.000717	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADH4—alcohol dependence	6.33e-05	0.000711	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.01e-05	0.000675	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADH6—alcohol dependence	5.93e-05	0.000665	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADH7—alcohol dependence	5.91e-05	0.000663	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GGT2—alcohol dependence	5.66e-05	0.000635	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—POMC—alcohol dependence	5.5e-05	0.000617	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	5.48e-05	0.000615	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADH7—alcohol dependence	5.43e-05	0.00061	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADH7—alcohol dependence	5.39e-05	0.000604	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GGT2—alcohol dependence	5.21e-05	0.000584	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADH1B—alcohol dependence	5.18e-05	0.000581	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GGT2—alcohol dependence	5.16e-05	0.000579	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADH1A—alcohol dependence	4.91e-05	0.000551	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADH1B—alcohol dependence	4.76e-05	0.000534	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADH1B—alcohol dependence	4.72e-05	0.00053	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MAOB—alcohol dependence	4.29e-05	0.000482	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADH4—alcohol dependence	4.18e-05	0.000469	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MAOB—alcohol dependence	3.95e-05	0.000443	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MAOB—alcohol dependence	3.91e-05	0.000439	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALDH2—alcohol dependence	3.65e-05	0.000409	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADH7—alcohol dependence	3.55e-05	0.000399	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.51e-05	0.000394	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GGT2—alcohol dependence	3.41e-05	0.000382	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALDH2—alcohol dependence	3.36e-05	0.000377	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALDH2—alcohol dependence	3.33e-05	0.000373	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.2e-05	0.000359	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.11e-05	0.000349	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GOT2—alcohol dependence	3.1e-05	0.000348	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2E1—alcohol dependence	2.92e-05	0.000327	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GOT2—alcohol dependence	2.85e-05	0.00032	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GOT2—alcohol dependence	2.83e-05	0.000317	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP2E1—alcohol dependence	2.68e-05	0.000301	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GGT1—alcohol dependence	2.68e-05	0.000301	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GOT1—alcohol dependence	2.68e-05	0.000301	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2E1—alcohol dependence	2.66e-05	0.000298	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MAOB—alcohol dependence	2.58e-05	0.00029	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GOT1—alcohol dependence	2.46e-05	0.000276	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GGT1—alcohol dependence	2.46e-05	0.000276	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GGT1—alcohol dependence	2.44e-05	0.000274	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GOT1—alcohol dependence	2.44e-05	0.000274	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MAOA—alcohol dependence	2.4e-05	0.000269	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.33e-05	0.000261	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MAOA—alcohol dependence	2.21e-05	0.000248	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.19e-05	0.000246	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MAOA—alcohol dependence	2.19e-05	0.000246	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.12e-05	0.000238	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GOT2—alcohol dependence	1.87e-05	0.000209	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.75e-05	0.000197	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GOT1—alcohol dependence	1.61e-05	0.000181	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GGT1—alcohol dependence	1.61e-05	0.000181	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—POMC—alcohol dependence	1.56e-05	0.000175	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MAOA—alcohol dependence	1.44e-05	0.000162	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—POMC—alcohol dependence	1.44e-05	0.000161	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—POMC—alcohol dependence	1.42e-05	0.00016	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—EP300—alcohol dependence	1.04e-05	0.000116	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—EP300—alcohol dependence	9.53e-06	0.000107	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—EP300—alcohol dependence	9.45e-06	0.000106	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—POMC—alcohol dependence	9.4e-06	0.000105	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—EP300—alcohol dependence	6.23e-06	6.99e-05	CbGpPWpGaD
